Students who attend George Washington University (GWU) participated in a survey, whether they know enough about medical cannabis. Due to the results of the research, 77% of the students want to have more official education on the medical properties of cannabis. 57.1% of future physicians said that they were ‘not prepared at all’ to discuss the benefits of medical cannabis.
Most medical students have already been asked by patients about the medical properties of cannabis, but most of them believe that the lack of cannabis education means that they are not prepared to discuss the use of this medicine.
According to a new study published in the Complementary Theories in Medicine, students from a leading American medical school stated that they were not receiving formal training on medical cannabis.
Explore the latest cannabis news, including what’s new in cannabis legalization, federal and state laws, politics, products, health, and culture. Read the latest news about Canada’s marijuana industry.
An online survey among medical students
The researchers conducted an online survey among students attending George Washington University (GWU) in Washington DC. The survey asked a number of questions about whether medical students received information about the benefits or risks of cannabis and whether they felt prepared to use this knowledge in their medical practice. 105 students responded to the survey, 37% of whom were first-year students. Students between the second and fourth years were about 20% each.
About 60% of respondents said they had received absolutely no information about cannabis. Only two participants said that the school had provided ‘enough’ knowledge about it. A majority of students (55.2%) said they had already met a patient who asked them about medical cannabis. Due to a lack of cannabis education, 57.1% of future physicians said that they were ‘not prepared at all’ to discuss the benefits of medical cannabis, and 54.1% felt unprepared to discuss potential risks.
Official education on the medical properties of cannabis
The survey also asked medical students whether they thought a school should offer more official education on the medical properties of cannabis. More than 77% of all respondents ‘agreed’ or ‘strongly agreed’ with this proposal. The authors of the study noted that the lack of formal medical education on cannabis in the GUU is ‘striking,’ given that medical cannabis has been legal in Washington since 2010, and that the adult use of cannabis for recreational purposes became legal in 2015.
“The apparent knowledge gap identified in this study indicates that American medical students could benefit from medical cannabis education,” the authors wrote. “These participants reported that they are not comfortable with their lack of knowledge about the risks and benefits of medical cannabis, and would like to learn more during their medical studies.”
The survey had a number of limitations, because only one particular medical school was surveyed and only about 12% of the school’s students responded to the survey. However, other surveys also indicated that almost 90% of medical school graduates felt unprepared to prescribe medical cannabis to patients.
73% of oncologists believe that cannabis could help fight cancer
A more recent study showed that although 73% of oncologists believed that cannabis could help fight cancer and the side effects of chemotherapy. 53% of them said they felt uncomfortable prescribing medical cannabis because of a lack of knowledge.
Medical cannabis is currently legal in 33 states, but most medical schools still do not offer adequate education on the benefits of this increasingly popular medicine. Many universities, including Northern Michigan University and Colorado State University, currently offer courses in cannabis biology and chemistry, but there are only a few courses focused on medical cannabis. To date, the University of Maryland School of Pharmacy is the only institution in the U.S. to offer a master’s program in medical cannabis.
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Hemp.im, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in faktykonopne.pl, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.